RE:Arch Biopartners - Real shareholder growth Yes Riverfolk you are spot on, we are trading on the OTCBB and Toronto Venture Exchange. Just wait until the 3rd party review and P3 starts. That is when they will be applying to the NYSE or NASDAQ. Once on their then the Institutional Investor can buy, and brokers can start recommending to their clients. Also the stock will become marginable where you can double your position. Also don't forget once above a certain market cap they will be eligible for being included in the Indexes IE Russell 2000., also biotech ETF. This is why from my very first post i have been emphatically stating that THE LITTLE GUY HAS THE ADVANTAGE OVER THE BIG BOYS in Arch Bio this will not last long. (my apologies for shouting)